Physician profile
Kelley L Hammis
NPI 1104804731
$9,670.81
in general payments reported to CMS, 2019-2025
7 companies · $3,940 in 2025
The $3,940 reported for 2025 was more than what 99% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.31 · 2022: $30.57 · 2023: $1,098 · 2024: $4,582 · 2025: $3,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,319 · Food and Beverage: $201 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,318.66 |
| Food and Beverage | $201.28 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $9,344.01 | 2023-2025 | Nexplanon |
| Astellas Pharma US INC | $143.50 | 2023-2025 | Veozah |
| Abbvie INC. | $54.40 | 2021-2024 | |
| Biogen, INC. | $53.45 | 2024-2025 | Zurzuvae |
| Medtronic, INC. | $38.42 | 2023 | V-Loc 180 |
| Sage Therapeutics, LLC | $21.01 | 2024 | |
| Pfizer INC. | $16.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelley Hammis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.